Mark Farag, MD
Pain Medicine · Des Plaines, ILNPI 1346565991
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,558 of the $7,616 with a category attached, or 86.1%. 13 manufacturers reported payments, led by Abbott at 40.6% of the total. Reporting peaked in 2019 at $3,445 and has fallen 89.1% since, to $374 in 2025.
Across 196 payments — averaging $38.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Electronic Waveform Lab, Inc.$2K
- Bioventus LLC$1K
- Si-bone, Inc.$207
- MML US, Inc.$182
- Painteq LLC$178
- plus $505 from 7 others
What the payments were for
- Travel & lodging$1,05714%
- Food & beverage$6,55886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 52 | $3,089 |
| Electronic Waveform Lab, Inc. | 119 | $2,347 |
| Bioventus LLC | 4 | $1,107 |
| Si-bone, Inc. | 3 | $207 |
| MML US, Inc. | 1 | $182 |
| Painteq LLC | 3 | $178 |
| Vertiflex, Inc. | 1 | $150 |
| Medtronic(2 entities) | 3 | $114 |
| AbbVie(2 entities) | 5 | $104 |
| Nalu Medical, Inc. | 2 | $92 |
| Merck | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Masimo Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Durolane$1,057
- PROCLAIM$772
- ETERNA$530
- Proclaim IPG$399
- Proclaim Family of SCS IPGs$292
- ReActiv8$182
- Superion ISS$150
- PAINTEQ$129
- iFuse Implant$104
How this compares
$7,616 in reported general payments places this provider in the 75th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $837 |
| Buprenorphine Hcl | 15 | $706 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 12 | $421 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Des Plaines
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Jay HurhLibertyville$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.